Abstract
Purpose
The introduction of new medicine can change clinical practice patterns and may affect patient outcomes. In the present study, we investigated whether introduction of remifentanil in Japan affected the practice patterns of anesthesia.
Methods
Using the Japanese Diagnosis Procedure Combination database, we extracted records of 423,491 patients who underwent surgery with general anesthesia in 243 hospitals before (2006) and after (2007) the introduction of remifentanil, and identified anesthetic agents used for each patient. A hierarchical mixed-effects logistic regression analysis was performed to analyze the factors that affected selection of remifentanil. Further, we compared postoperative length of stay (LOS), in-hospital mortality, and total costs between 2006 and 2007.
Results
In 2007, remifentanil was used for up to 41.4% of all general anesthesia, accompanied by a reduction in nitrous oxide use and an increase in total intravenous anesthesia. Female gender, increasing age, and preoperative comorbidities including diabetes mellitus, hypertension, liver cirrhosis, and chronic renal failure were positively associated with the use of remifentanil, whereas accompanying cardiac disease and co-application of epidural anesthesia were negatively associated. In 2007, a similar in-hospital death rate, similar or decreased total costs, slightly reduced duration of anesthesia, and substantially reduced postoperative LOS were seen compared to those in 2006.
Conclusions
Our data revealed rapid changes in practice patterns in anesthesia after the introduction of remifentanil in Japan. Remifentanil was used more often in patients with comorbidities and without epidural anesthesia, and its introduction did not affect increase in total medical costs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Horiguchi H, Yasunaga H, Hashimoto H, Matsuda S. Impact of drug-eluting stents on treatment option mix for coronary artery disease in Japan. Circ J. 2010;74:1635–43.
van Vollenhoven RF. Treatment of rheumatoid arthritis: state of the art 2009. Nat Rev Rheumatol. 2009;5:531–41.
Ligthart S, Vlemmix F, Dendukuri N, Brophy JM. The cost-effectiveness of drug-eluting stents: a systematic review. CMAJ. 2007;176:199–205.
Clergue F, Auroy Y, Péquignot F, Jougla E, Lienhart A, Laxenaire MC. French survey of anesthesia in 1996. Anesthesiology. 1999;91:1509–20.
Cohen MM, Rose DK, Yee DA. Changing anesthesiologists’ practice patterns. Can it be done? Anesthesiology. 1996;85:260–9.
Egan TD. Remifentanil pharmacokinetics and pharmacodynamics. A preliminary appraisal. Clin Pharmacokinet. 1995;29:80–94.
Kapila A, Glass PS, Jacobs JR, Muir KT, Hermann DJ, Shiraishi M, Howell S, Smith RL. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology. 1995;83:968–75.
Komatsu R, Turan AM, Orhan-Sungur M, McGuire J, Radke OC, Apfel CC. Remifentanil for general anaesthesia: a systematic review. Anaesthesia. 2007;62:1266–80.
Matsuda S, Ishikawa KB, Kuwabara K, Fujimori K, Fushimi K, Hashimoto H. Development and use of the Japanese case-mix system. Eurohealth. 2008;14:25–30.
Sumitani M, Uchida K, Yasunaga H, Horiguchi H, Kusakabe Y, Matsuda S, Yamada Y. Prevalence of malignant hyperthermia and relationship with anesthetics in Japan. Data from the diagnosis procedure combination database. Anesthesiology. 2011;114:84–90.
Kuwabara K, Matsuda S, Imanaka Y, Fushimi K, Hashimoto H, Ishikawa KB, Horiguchi H, Hayashida K, Fujimori K, Ikeda S, Yasunaga H. Injury severity score, resource use, and outcome for trauma patients within a Japanese administrative database. J Trauma. 2010;68:463–70.
Yasunaga H, Yanaihara H, Fuji K, Horiguchi H, Hashimoto H, Matsuda S. Impact of hospital volume on postoperative complications and in-hospital mortality following renal surgery: data from the Japanese Diagnosis Procedure Combination Database. Urology. 2010;76:548–52.
Matsui H, Hashimoto H, Horiguchi H, Yasunaga H, Matsuda S. An exploration of the association between very early rehabilitation and outcome for the patients with acute ischaemic stroke in Japan: a nationwide retrospective cohort survey. BMC Health Serv Res. 2010;10:213.
Park B, Messina L, Dargon P, Huang W, Ciocca R, Anderson FA. Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the Nationwide Inpatient Sample. Chest. 2009;136:983–90.
Morita K, Kawashima Y, Irita K, Iwao Y, Seo N, Tsuzaki K. Perioperative mortality and morbidity in the year 2000 in 520 certified training hospitals of Japanese Society of Anesthesiologists with a special reference to age: report of Japanese Society of Anesthesiologists Committee on Operating Room Safety. Masui (Jpn J Anesthesiol). 2002;51:1285–1296 (in Japanese with English abstract).
Iwao Y, Kawashima Y, Seo N, Kobayashi T, Goto Y, Morita K, Irita K, Tsuzaki K, Dohi S, Tanaka Y, Shiraishi Y, Tozaki Y, Nakao Y, Japan Society of Anesthesiologist Committee on Operating Room Safety. Perioperative mortality and morbidity for the year 2000 in 532 Japanese Society of Anesthesiologists certified training hospitals with a special reference to surgical sites: report of the Japan Society of Anesthesiologists Committee on Operating Room Safety. Masui (Jpn J Anesthesiol). 2002;51:791–800 (in Japanese with English abstract).
McGavock H, Webb CH, Johnston GD, Milligan E. Market penetration of new drugs in one United Kingdom region: implications for general practitioners and administrators. Br Med J. 1993;307:1118–20.
Block BM, Liu SS, Rowlingson AJ, Cowan AR, Cowan JA Jr, Wu CL. Efficacy of postoperative epidural analgesia: a meta-analysis. JAMA. 2003;290:2455–63.
Liu S, Carpenter RL, Neal JM. Epidural anesthesia and analgesia. Their role in postoperative outcome. Anesthesiology. 1995;82:1474–506.
Elliott P, O’Hare R, Bill KM, Phillips AS, Gibson FM, Mirakhur RK. Severe cardiovascular depression with remifentanil. Anesth Analg. 2000;91:58–61.
Pedersen T. Evidence-based anaesthesia and health economics. Best Pract Res Clin Anaesthesiol. 2006;20:347–60.
Scott LJ, Perry CM. Spotlight on remifentanil for general anaesthesia. CNS Drugs. 2005;19:1069–74.
Nomura H, Nakayama T. The Japanese healthcare system: the issue is to solve the “tragedy of the commons” without making another. Br Med J. 2005;331:648–9.
Stachnik J. Inhaled anesthetic agents. Am J Health Syst Pharm. 2006;63:623–34.
Apfel CC, Korttila K, Abdalla M, Kerger H, Turan A, Vedder I, Zernak C, Danner K, Jokela R, Pocock SJ, Trenkler S, Kredel M, Biedler A, Sessler DI, Roewer N, IMPACT Investigators. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med. 2004;350:2441–51.
De Hert SG, Turani F, Mathur S, Stowe DF. Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth Analg. 2005;100:1584–93.
von Dossow V, Luetz A, Haas A, Sawitzki B, Wernecke KD, Volk HD, Spies CD. Effects of remifentanil and fentanyl on the cell-mediated immune response in patients undergoing elective coronary artery bypass graft surgery. J Int Med Res. 2008;36:1235–47.
Fearon KC, Ljungqvist O, Von Meyenfeldt M, Revhaug A, Dejong CH, Lassen K, Nygren J, Hausel J, Soop M, Andersen J, Kehlet H. Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr. 2005;24:466–7.
Acknowledgments
This study was funded by Grants-in-Aid for Research on Policy Planning and Evaluation (grant number: H19-Policy-001) from the Ministry of Health, Labour and Welfare, Japan.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Uchida, K., Yasunaga, H., Miyata, H. et al. Impact of remifentanil introduction on practice patterns in general anesthesia. J Anesth 25, 864–871 (2011). https://doi.org/10.1007/s00540-011-1221-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-011-1221-5